Wells Fargo’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $223K | Sell |
|
|||||
|
2019
Q4 | $795K | Buy |
|
|||||
|
2019
Q3 | $579K | Buy |
|
|||||
|
2019
Q2 | $698K | Sell |
|
|||||
|
2019
Q1 | $2.66M | Buy |
|
|||||
|
2018
Q4 | $481K | Buy |
|
|||||
|
2018
Q3 | $695K | Buy |
|
|||||
|
2018
Q2 | $860K | Sell |
|
|||||
|
2018
Q1 | $1.35M | Sell |
|
|||||
|
2017
Q4 | $1.28M | Buy |
|
|||||
|
2017
Q3 | $1.54M | Buy |
|
|||||
|
2017
Q2 | $1.11M | Sell |
|
|||||
|
2017
Q1 | $1.76M | Sell |
|
|||||
|
2016
Q4 | $1.73M | Buy |
|
|||||
|
2016
Q3 | $464K | Buy |
|
|||||
|
2016
Q2 | $308K | Sell |
|
|||||
|
2016
Q1 | $343K | Buy |
|
|||||
|
2015
Q4 | $463K | Buy |
|
|||||
|
2015
Q3 | $113K | Sell |
|
|||||
|
2015
Q2 | $276K | Buy |
|
|||||
|
2015
Q1 | $33K | Buy |
|
|||||
|
2014
Q4 | $24K | Buy |
|
|||||
|
2014
Q3 | $17K | Sell |
|
|||||
|
2014
Q2 | $27K | Buy |
|